Drug Markets/Trolamine Salicylate

Trolamine Salicylate

3 NDCs across 2 manufacturers|1 Generic,2 Brand

Trolamine Salicylate is used to treat pain, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Trolamine Salicylate is available as 3 NDCs from 2 manufacturers (1 generic, 2 brand), with NADAC prices from $0.03 to $0.05 per GM — a 45% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

1G / 2B

Manufacturers

2

competing in market

Price Spread

$0.03 – $0.05

per GM

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing TROLAMINE SALICYLATE

Drug Portfolio

3 NDCs total, 3 shown

Drug ↕Price 7d Change ↕
MOBISYL 10% CREAM
$0.0497
per GM
—
MOBISYL 10% CREAM
$0.0454
per GM
—
PAIN RELIEVING 10% CREAM
$0.0344
per GM
—

Frequently Asked Questions

What is Trolamine Salicylate used to treat?

Trolamine Salicylate is used to treat pain, per the National Library of Medicine's MED-RT classification.

How many Trolamine Salicylate products are on the market?

The Trolamine Salicylate drug market contains 3 NDCs from 2 manufacturers — 1 generic and 2 brand products.

What is the price range for Trolamine Salicylate?

NADAC reference prices for Trolamine Salicylate range from $0.0344 to $0.0497 per GM — a 45% difference between cheapest and most expensive.

Is generic Trolamine Salicylate cheaper than brand?

The average generic NADAC for Trolamine Salicylate is $0.0344 per GM, versus $0.0476 for brand-labeled products — generic is about 28% cheaper on average.

Which manufacturers make Trolamine Salicylate?

2 manufacturers list Trolamine Salicylate in NADAC. Ranked by number of NDCs, the largest are BF ASCHER AND CO INC (2), Cardinal Health (1).